The term frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) was defined in 1996 during the International Consensus Conference in Ann Arbor, Michigan (3). At the time of this meeting, only 13 families with syndromes linked to the chromosome 17q21-22 locus were known (4-12). Currently, over 80 families with FTDP-17 are known (13). Data indicate that some of these kindreds may share a common founder (14,15). However, distribution is worldwide, with families described in North America, Europe, Asia, and Australia (4-14,16).
Molecular genetic studies have identified 31 unique tau gene mutations associated with FTDP-17 (8,10-12,14,16). The three most prevalent are P301L, exon 10 5' +16, and N279K. These mutations account for about 60% of known cases of FTDP-17 (16). Thus, the concept of FTDP-17 has evolved
From: Current Clinical Neurology: Atypical Parkinsonian Disorders Edited by: I. Litvan © Humana Press Inc., Totowa, NJ
Familial Parkinsonism Associated With Known Gene Mutations or Loci
Range of Age at Onset, yr (mean)
Response to Levodopa
Was this article helpful?
The comprehensive new ebook All About Alzheimers puts everything into perspective. Youll gain insight and awareness into the disease. Learn how to maintain the patients emotional health. Discover tactics you can use to deal with constant life changes. Find out how counselors can help, and when they should intervene. Learn safety precautions that can protect you, your family and your loved one. All About Alzheimers will truly empower you.